APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Selected research

Market Structure

Global Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.

This report provides an overview of the global Radiopharmaceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Radiopharmaceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiopharmaceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiopharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Radiopharmaceuticals Segment by Company

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Radiopharmaceuticals Segment by Type

Diagnostic Radioisotopes

Therapeutic Radioisotopes

Radiopharmaceuticals Segment by Application

Oncology

Cardiology

Other

Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radiopharmaceuticals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Radiopharmaceuticals Industry Trends Table 2. Radiopharmaceuticals Industry Drivers Table 3. Radiopharmaceuticals Industry Opportunities and Challenges Table 4. Radiopharmaceuticals Industry Restraints Table 5. Global Radiopharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Radiopharmaceuticals Sales by Manufacturers (K Dose) & (2021-2026) Table 8. Global Radiopharmaceuticals Sales Market Share by Manufacturers Table 9. Global Radiopharmaceuticals Average Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 10. Global Radiopharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Radiopharmaceuticals Manufacturers, Product Type & Application Table 13. Global Radiopharmaceuticals Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Radiopharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Diagnostic Radioisotopes Table 17. Major Manufacturers of Therapeutic Radioisotopes Table 18. Global Radiopharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (K Dose) Table 19. Global Radiopharmaceuticals Sales by Type (2021-2026) & (K Dose) Table 20. Global Radiopharmaceuticals Sales by Type (2027-2032) & (K Dose) Table 21. Global Radiopharmaceuticals Sales Market Share by Type (2021-2026) Table 22. Global Radiopharmaceuticals Sales Market Share by Type (2027-2032) Table 23. Global Radiopharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (K Dose) Table 24. Global Radiopharmaceuticals Revenue by Type (2021-2026) & (K Dose) Table 25. Global Radiopharmaceuticals Revenue by Type (2027-2032) & (K Dose) Table 26. Global Radiopharmaceuticals Revenue Market Share by Type (2021-2026) Table 27. Global Radiopharmaceuticals Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Oncology Table 29. Major Manufacturers of Cardiology Table 30. Major Manufacturers of Other Table 31. Global Radiopharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (K Dose) Table 32. Global Radiopharmaceuticals Sales by Application (2021-2026) & (K Dose) Table 33. Global Radiopharmaceuticals Sales by Application (2027-2032) & (K Dose) Table 34. Global Radiopharmaceuticals Sales Market Share by Application (2021-2026) Table 35. Global Radiopharmaceuticals Sales Market Share by Application (2027-2032) Table 36. Global Radiopharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (K Dose) Table 37. Global Radiopharmaceuticals Revenue by Application (2021-2026) & (K Dose) Table 38. Global Radiopharmaceuticals Revenue by Application (2027-2032) & (K Dose) Table 39. Global Radiopharmaceuticals Revenue Market Share by Application (2021-2026) Table 40. Global Radiopharmaceuticals Revenue Market Share by Application (2027-2032) Table 41. Global Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Dose) Table 42. Global Radiopharmaceuticals Sales by Region (2021-2026) & (K Dose) Table 43. Global Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 44. Global Radiopharmaceuticals Sales Forecasted by Region (2027-2032) & (K Dose) Table 45. Global Radiopharmaceuticals Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Dose) Table 47. North America Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 48. North America Radiopharmaceuticals Sales by Country (2027-2032) & (K Dose) Table 49. Europe Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Dose) Table 50. Europe Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 51. Europe Radiopharmaceuticals Sales by Country (2027-2032) & (K Dose) Table 52. Asia Pacific Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Dose) Table 53. Asia Pacific Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 54. Asia Pacific Radiopharmaceuticals Sales by Country (2027-2032) & (K Dose) Table 55. South America, Middle East and Africa Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Dose) Table 56. South America, Middle East and Africa Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 57. South America, Middle East and Africa Radiopharmaceuticals Sales by Country (2027-2032) & (K Dose) Table 58. Global Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Radiopharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Radiopharmaceuticals Revenue Market Share by Region (2021-2026) Table 62. Global Radiopharmaceuticals Revenue Market Share by Region (2027-2032) Table 63. Bracco Imaging Company Information Table 64. Bracco Imaging Business Overview Table 65. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bracco Imaging Radiopharmaceuticals Product Portfolio Table 67. Bracco Imaging Recent Development Table 68. Bayer Company Information Table 69. Bayer Business Overview Table 70. Bayer Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bayer Radiopharmaceuticals Product Portfolio Table 72. Bayer Recent Development Table 73. Mallinckrodt Company Information Table 74. Mallinckrodt Business Overview Table 75. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Mallinckrodt Radiopharmaceuticals Product Portfolio Table 77. Mallinckrodt Recent Development Table 78. Nordion Company Information Table 79. Nordion Business Overview Table 80. Nordion Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Nordion Radiopharmaceuticals Product Portfolio Table 82. Nordion Recent Development Table 83. Triad Isotopes Company Information Table 84. Triad Isotopes Business Overview Table 85. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Triad Isotopes Radiopharmaceuticals Product Portfolio Table 87. Triad Isotopes Recent Development Table 88. Lantheus Company Information Table 89. Lantheus Business Overview Table 90. Lantheus Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Lantheus Radiopharmaceuticals Product Portfolio Table 92. Lantheus Recent Development Table 93. IBA Group Company Information Table 94. IBA Group Business Overview Table 95. IBA Group Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. IBA Group Radiopharmaceuticals Product Portfolio Table 97. IBA Group Recent Development Table 98. GE Healthcare Company Information Table 99. GE Healthcare Business Overview Table 100. GE Healthcare Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. GE Healthcare Radiopharmaceuticals Product Portfolio Table 102. GE Healthcare Recent Development Table 103. China Isotope & Radiation Company Information Table 104. China Isotope & Radiation Business Overview Table 105. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. China Isotope & Radiation Radiopharmaceuticals Product Portfolio Table 107. China Isotope & Radiation Recent Development Table 108. Jubilant Pharma Company Information Table 109. Jubilant Pharma Business Overview Table 110. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Jubilant Pharma Radiopharmaceuticals Product Portfolio Table 112. Jubilant Pharma Recent Development Table 113. Eli Lilly Company Information Table 114. Eli Lilly Business Overview Table 115. Eli Lilly Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Eli Lilly Radiopharmaceuticals Product Portfolio Table 117. Eli Lilly Recent Development Table 118. Advanced Accelerator Applications Company Information Table 119. Advanced Accelerator Applications Business Overview Table 120. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio Table 122. Advanced Accelerator Applications Recent Development Table 123. SIEMENS Company Information Table 124. SIEMENS Business Overview Table 125. SIEMENS Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. SIEMENS Radiopharmaceuticals Product Portfolio Table 127. SIEMENS Recent Development Table 128. Dongcheng Company Information Table 129. Dongcheng Business Overview Table 130. Dongcheng Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Dongcheng Radiopharmaceuticals Product Portfolio Table 132. Dongcheng Recent Development Table 133. Navidea Company Information Table 134. Navidea Business Overview Table 135. Navidea Radiopharmaceuticals Sales (K Dose), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Navidea Radiopharmaceuticals Product Portfolio Table 137. Navidea Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Radiopharmaceuticals Distributors List Table 141. Radiopharmaceuticals Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Radiopharmaceuticals Product Image Figure 2. Global Radiopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceuticals Sales (2021-2032) & (K Dose) Figure 5. Global Radiopharmaceuticals Average Price (US$/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 Radiopharmaceuticals Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Diagnostic Radioisotopes Image Figure 9. Therapeutic Radioisotopes Image Figure 10. Global Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (K Dose) Figure 11. Global Radiopharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Radiopharmaceuticals Sales Market Share by Type (2021-2032) Figure 13. Global Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (K Dose) Figure 14. Global Radiopharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Radiopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 16. Oncology Image Figure 17. Cardiology Image Figure 18. Other Image Figure 19. Global Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (K Dose) Figure 20. Global Radiopharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Radiopharmaceuticals Sales Market Share by Application (2021-2032) Figure 22. Global Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (K Dose) Figure 23. Global Radiopharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Radiopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 25. North America Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 26. North America Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 27. U.S. Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 28. Canada Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 29. Mexico Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 30. Europe Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 31. Europe Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 32. Germany Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 33. France Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 34. U.K. Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 35. Italy Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 36. Netherlands Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 37. Asia Pacific Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 38. Asia Pacific Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 39. China Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 40. Japan Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 41. South Korea Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 42. Southeast Asia Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 43. India Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 44. Australia Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 45. South America, Middle East and Africa Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 46. South America, Middle East and Africa Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 47. Brazil Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 48. South Africa Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 49. Saudi Arabia Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 50. Turkey Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 51. Argentina Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 52. UAE Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 53. Egypt Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 54. Chile Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Dose) Figure 55. Global Radiopharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 58. North America Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 60. Europe Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Radiopharmaceuticals Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Radiopharmaceuticals Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Radioisotopes
  • Therapeutic Radioisotopes
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Radiopharmaceuticals Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Radiopharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Radiopharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Radiopharmaceuticals Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Radiopharmaceuticals Market Dynamics
  1. 2.1 Radiopharmaceuticals Industry Trends
  2. 2.2 Radiopharmaceuticals Industry Drivers
  3. 2.3 Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceuticals Industry Restraints
3 Radiopharmaceuticals Market by Manufacturers
  1. 3.1 Global Radiopharmaceuticals Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Radiopharmaceuticals Sales by Manufacturers (2021-2026)
  3. 3.3 Global Radiopharmaceuticals Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Radiopharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Radiopharmaceuticals Manufacturers, Product Type & Application
  7. 3.7 Global Radiopharmaceuticals Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radiopharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radiopharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Radiopharmaceuticals Market by Type
  1. 4.1 Radiopharmaceuticals Type Introduction
  2. 4.1.1 Diagnostic Radioisotopes
  3. 4.1.2 Therapeutic Radioisotopes
  4. 4.2 Global Radiopharmaceuticals Sales by Type
  5. 4.2.1 Global Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Radiopharmaceuticals Sales by Type (2021-2032)
  7. 4.2.3 Global Radiopharmaceuticals Sales Market Share by Type (2021-2032)
  8. 4.3 Global Radiopharmaceuticals Revenue by Type
  9. 4.3.1 Global Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Radiopharmaceuticals Revenue by Type (2021-2032)
  11. 4.3.3 Global Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
5 Radiopharmaceuticals Market by Application
  1. 5.1 Radiopharmaceuticals Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Radiopharmaceuticals Sales by Application
  6. 5.2.1 Global Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiopharmaceuticals Sales by Application (2021-2032)
  8. 5.2.3 Global Radiopharmaceuticals Sales Market Share by Application (2021-2032)
  9. 5.3 Global Radiopharmaceuticals Revenue by Application
  10. 5.3.1 Global Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Radiopharmaceuticals Revenue by Application (2021-2032)
  12. 5.3.3 Global Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
6 Global Radiopharmaceuticals Sales by Region
  1. 6.1 Global Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radiopharmaceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Radiopharmaceuticals Sales by Region (2021-2026)
  4. 6.2.2 Global Radiopharmaceuticals Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Radiopharmaceuticals Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Radiopharmaceuticals Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Radiopharmaceuticals Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Radiopharmaceuticals Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Radiopharmaceuticals Revenue by Region
  1. 7.1 Global Radiopharmaceuticals Revenue by Region
  2. 7.1.1 Global Radiopharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Radiopharmaceuticals Revenue by Region (2021-2026)
  4. 7.1.3 Global Radiopharmaceuticals Revenue by Region (2027-2032)
  5. 7.1.4 Global Radiopharmaceuticals Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Radiopharmaceuticals Revenue (2021-2032)
  8. 7.2.2 North America Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Radiopharmaceuticals Revenue (2021-2032)
  11. 7.3.2 Europe Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Radiopharmaceuticals Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Radiopharmaceuticals Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bracco Imaging
  2. 8.1.1 Bracco Imaging Company Information
  3. 8.1.2 Bracco Imaging Business Overview
  4. 8.1.3 Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bracco Imaging Radiopharmaceuticals Product Portfolio
  6. 8.1.5 Bracco Imaging Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Radiopharmaceuticals Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Mallinckrodt
  14. 8.3.1 Mallinckrodt Company Information
  15. 8.3.2 Mallinckrodt Business Overview
  16. 8.3.3 Mallinckrodt Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mallinckrodt Radiopharmaceuticals Product Portfolio
  18. 8.3.5 Mallinckrodt Recent Developments
  19. 8.4 Nordion
  20. 8.4.1 Nordion Company Information
  21. 8.4.2 Nordion Business Overview
  22. 8.4.3 Nordion Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nordion Radiopharmaceuticals Product Portfolio
  24. 8.4.5 Nordion Recent Developments
  25. 8.5 Triad Isotopes
  26. 8.5.1 Triad Isotopes Company Information
  27. 8.5.2 Triad Isotopes Business Overview
  28. 8.5.3 Triad Isotopes Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Triad Isotopes Radiopharmaceuticals Product Portfolio
  30. 8.5.5 Triad Isotopes Recent Developments
  31. 8.6 Lantheus
  32. 8.6.1 Lantheus Company Information
  33. 8.6.2 Lantheus Business Overview
  34. 8.6.3 Lantheus Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lantheus Radiopharmaceuticals Product Portfolio
  36. 8.6.5 Lantheus Recent Developments
  37. 8.7 IBA Group
  38. 8.7.1 IBA Group Company Information
  39. 8.7.2 IBA Group Business Overview
  40. 8.7.3 IBA Group Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 IBA Group Radiopharmaceuticals Product Portfolio
  42. 8.7.5 IBA Group Recent Developments
  43. 8.8 GE Healthcare
  44. 8.8.1 GE Healthcare Company Information
  45. 8.8.2 GE Healthcare Business Overview
  46. 8.8.3 GE Healthcare Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GE Healthcare Radiopharmaceuticals Product Portfolio
  48. 8.8.5 GE Healthcare Recent Developments
  49. 8.9 China Isotope & Radiation
  50. 8.9.1 China Isotope & Radiation Company Information
  51. 8.9.2 China Isotope & Radiation Business Overview
  52. 8.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 China Isotope & Radiation Radiopharmaceuticals Product Portfolio
  54. 8.9.5 China Isotope & Radiation Recent Developments
  55. 8.10 Jubilant Pharma
  56. 8.10.1 Jubilant Pharma Company Information
  57. 8.10.2 Jubilant Pharma Business Overview
  58. 8.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jubilant Pharma Radiopharmaceuticals Product Portfolio
  60. 8.10.5 Jubilant Pharma Recent Developments
  61. 8.11 Eli Lilly
  62. 8.11.1 Eli Lilly Company Information
  63. 8.11.2 Eli Lilly Business Overview
  64. 8.11.3 Eli Lilly Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Eli Lilly Radiopharmaceuticals Product Portfolio
  66. 8.11.5 Eli Lilly Recent Developments
  67. 8.12 Advanced Accelerator Applications
  68. 8.12.1 Advanced Accelerator Applications Company Information
  69. 8.12.2 Advanced Accelerator Applications Business Overview
  70. 8.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio
  72. 8.12.5 Advanced Accelerator Applications Recent Developments
  73. 8.13 SIEMENS
  74. 8.13.1 SIEMENS Company Information
  75. 8.13.2 SIEMENS Business Overview
  76. 8.13.3 SIEMENS Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 SIEMENS Radiopharmaceuticals Product Portfolio
  78. 8.13.5 SIEMENS Recent Developments
  79. 8.14 Dongcheng
  80. 8.14.1 Dongcheng Company Information
  81. 8.14.2 Dongcheng Business Overview
  82. 8.14.3 Dongcheng Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Dongcheng Radiopharmaceuticals Product Portfolio
  84. 8.14.5 Dongcheng Recent Developments
  85. 8.15 Navidea
  86. 8.15.1 Navidea Company Information
  87. 8.15.2 Navidea Business Overview
  88. 8.15.3 Navidea Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Navidea Radiopharmaceuticals Product Portfolio
  90. 8.15.5 Navidea Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radiopharmaceuticals Value Chain Analysis
  2. 9.1.1 Radiopharmaceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radiopharmaceuticals Production Mode & Process
  6. 9.2 Radiopharmaceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radiopharmaceuticals Distributors
  9. 9.2.3 Radiopharmaceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst